Ban on risky, doubtful meds eyed in India

11/13/2013 | PharmaBiz.com (India)

Doubtful and dangerous drugs will be barred soon by India's Ministry of Health and Family Welfare. A "special expert committee" will be established by the ministry to assess drug formulations and determine which medicines are potentially risky or of uncertain therapeutic efficacy. "If two or more countries remove a drug from their market on grounds of efficacy and safety, then the continued marketing of the drug in the country will be considered for examination and appropriate action," ministry officials said.

View Full Article in:

PharmaBiz.com (India)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY